GlucoMe, a comprehensive, digital diabetes care platform that intends to streamlines the disease management process for patients, medical teams and healthcare providers, announced yesterday that it has collaborated with Switzerland-based Roche as a new partner due to its involvement in the current Startup Creasphere Batch 2 Program.
Set-up by Roche and Plug and Play to accelerate digital healthcare Startup Creasphere is the first digital health innovation hub in Europe. GlucoMe was chosen to collaborate with Roche from one of 11 companies that are participating in the global initiative, following a screening process of more than 200 health-focused start-up companies.
GlucoMe's CEO, Yiftah Ben-Aharon, said, 'We are excited to partner with Roche and Plug & Play. From some very tough competition involving world-class promising digital health start-ups, the new Roche partnership will help GlucoMe rapidly advance our digital diabetes platform to set a new standard in diabetes care delivery.'
Adocia files patent for long-acting peptide platform AdoXLong and updates on BioChaperone studies
10XREVIV Launch Announced in Abu Dhabi Through Partnership Between 10X Health, REVIV Global and M42
Terns Pharmaceuticals reports topline 12-week data from Phase 2 trial of TERN-601 in obesity
Ascletis selects once-monthly SQ GLP-1R/GIPR dual peptide agonist, ASC35, for clinical development
Celltrion's biosimilar EYDENZELT (aflibercept-boav) approved by US FDA
Novo Nordisk to acquire Akero Therapeutics in USD5.2bn deal to strengthen MASH pipeline